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Abstract: Cnidarian constitutes a great source of bioactive compounds. However, research involving
peptides from organisms belonging to the order Zoanthidea has received very little attention, contrasting
to the numerous studies of the order Actiniaria, from which hundreds of toxic peptides and proteins
have been reported. In this work, we performed a mass spectrometry analysis of a low molecular
weight (LMW) fraction previously reported as lethal to mice. The low molecular weight (LMW) fraction
was obtained by gel filtration of a Zoanthus sociatus (order Zoanthidea) crude extract with a Sephadex
G-50, and then analyzed by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight
(MALDI-TOF/TOF) mass spectrometry (MS) in positive ion reflector mode from m/z 700 to m/z 4000.
Afterwards, some of the most intense and representative MS ions were fragmented by MS/MS
with no significant results obtained by Protein Pilot protein identification software and the Mascot
algorithm search. However, microcystin masses were detected by mass-matching against libraries of
non-ribosomal peptide database (NORINE). Subsequent reversed-phase C18 HPLC (in isocratic
elution mode) and mass spectrometry analyses corroborated the presence of the cyanotoxin
Microcystin-LR (MC-LR). To the best of our knowledge, this finding constitutes the first report
of MC-LR in Z. sociatus, and one of the few evidences of such cyanotoxin in cnidarians.
Keywords: microcystins; MC-LR; Zoanthus sociatus; zoanthidea; cnidarian; Sephadex G50;
MALDI-TOF/TOF
1. Introduction
Cnidarians represent promising sources of bioactive compounds, which can be of major
pharmacological [1] and therapeutic interest [2–4]. However, many organisms belonging to the
order Actiniaria (sea anemones), of the class Anthozoa, have been so far studied [5–8]. In contrast, the
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order Zoanthidea has been scarcely explored for biologically active compounds, although some potent
non-peptide toxins, such as palytoxin and its analogues, have been characterized from this order [9–11].
Additionally, a peptide exhibiting a reversible delay of tetrodotoxin (TTX)-sensitive sodium channel
inactivation, was isolated and characterized from Palythoa caribaeorum exudate, but its sequence
does not resemble any cnidarian toxin previously reported [12]. In another study the exudate of
P. caribaeourum provoked reversible delay of the inactivation process of voltage-gated sodium channels
(NaV1.7), inhibited voltage-gated calcium (CaV2.2) and delayed rectifier (IDR) currents of KV channels
from rat superior cervical ganglion (SCG) neurons [12]. The matrix-assisted laser desorption/ionization
time-of-flight/time-of-flight (MALDI-TOF/TOF) mass spectrometry (MS) analyses provided evidence
of low molecular weight peptides involved in such effects on ion channels. It is also noteworthy
the transcriptomic analysis on Protopalythoa variabilis, at which a transcript encoded a toxin called
ShK/Aurelin-like that was toxic to zebrafish embryos [13].
Zoanthus sociatus also belongs to the order Zoanthidea. To date, few chemical studies have been
reported from this organism, comprising the isolation and characterization of small non-proteinaceous
molecules, such as the sterol zoanthosterol [14], as well as the norzoanthamines alkaloids and their
analogues [15,16]. In addition to these bioactive compounds, an antifilarial activity from the Z. sociatus
chloroform/methanol extract was reported [17]. Moreover, only two reports on the toxicity of the crude
extract and semi-pure chromatographic fractions have been published. The first study demonstrated
that Z. sociatus components below 7 kDa are responsible for the inhibition of insulin secretion mediated
by Ca2+ influx blockade in isolated rat β cells [18]. A further study showed the biological evaluation of
a low molecular weight (LMW) Sephadex G-50-chromatographic fraction lethal to mice, presumably
by cardiorespiratory arrest [19].
Information provided in previous studies about the molecular mass profile of the low molecular
weight (LMW) fraction from Z. sociatus showed components in the m/z range from 700 to 6000 [18,19].
Nonetheless, the mass spectrometry analysis of a LMW fraction obtained by the same methodology
showed many m/z signals below 1000 [19]. Yet, the identification of the main components of the
fraction remains to be done, thus, our main goal being the MALDI-TOF/TOF mass spectrometry
analysis to characterize the most significant components of a LMW fraction from Z. sociatus. First,
we performed the acquisition of a MALDI-TOF/TOF MS spectrum of the LMW fraction followed by
MS/MS fragmentation of the most significant signals. In general, the obtained data did not allow the
identification of sea anemones-like peptide toxins or linear peptides using the Protein Pilot protein
identification software or the Mascot algorithm search [20].
On the other hand, m/z signals from known cyanotoxins were detected by mass-matching against
libraries of non-ribosomal peptide database (NORINE) [21,22]. Indeed, within the microcystins masses
detected, the m/z 995.53 matched the expected m/z signal for microcystin-LR (MC-LR). The presence of
MC-LR was further demonstrated by high-resolution mass spectrometry analysis. While microcystins
are recognized as freshwater cyanobacterial toxins, the occurrence of microcystins in marine ecosystems
is not an isolated fact [23–27]. However, our findings constitute one of the few evidence of such
cyanotoxin detected in cnidarians [28], and to the best of our knowledge the first report in Z. sociatus.
Additionally, this work calls for further attention to the probabilities of water and food contamination
by microcystins in tropical regions.
2. Results and Discussion
2.1. Gel Filtration in Sephadex G-50
The first purification step of the Z. sociatus crude extract was achieved by fractionation on
Sephadex G-50. As previously described, the gel filtration chromatogram was divided into four
fractions [19]. The resulting chromatogram showed the same elution profile of Z. sociatus crude extract,
obtained by a similar purification protocol on HiLoad 16/20 Superdex 75 column [18]. The third
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fraction, called Zs G50-III, was then submitted to MALDI-TOF/TOF mass spectrometry analysis, given
its lethal effect on mice as previously reported [19].
2.2. Zs G50-III MALDI-TOF/TOF Analysis
The selected fraction Zs G50-III was analyzed by MALDI-TOF/TOF MS analysis in positive
ion reflector mode in the m/z range from 700 to 4000. The most intense signal detected in the
MALDI-TOF/TOF MS analysis corresponded to m/z values below 2000, resulting in the detection of
142 signals, ranging from m/z 703.93 to 1336.96. The highest intensity signals are shown in Figure 1.
Afterwards, some of the most intense and representative MS ions corresponding to m/z 876.98, 861.01,
1050.04, and 1066.00 were fragmented by MS/MS (Figures 2 and 3). Then, all the data generated by the
MALDI-TOF/TOF procedure were submitted to search with the Mascot (Matrix-Science, London, UK)
algorithm against UniProtKB protein sequence database [29], specifically in the Metazoan and Cnidaria
section. Additionally, the spectra were also analyzed with the Protein Pilot protein identification
software v4.5 (AB SCIEX). No significant result was obtained by any of the mentioned methods.
The fragmentation pattern of the selected ions showed scarce peaks. In fact, the spectra do not
resemble those of linear peptides, but seem to be related to cyclo-peptides fragmentation.
On the other hand, cyanotoxins-related masses were detected by peak list mass-matching against
libraries of non-ribosomal peptide database (NORINE). Indeed, some of the most intense signals
were related to microcystins. The mass m/z 1066.00 matched a reported microcystin [9-acetyl-Adda5]-
MC-RR [30]. Furthermore, the MS/MS analyses of m/z 1066.00 showed a high intensity signal at
m/z 876.94 (Figure 2). Besides, in the MS/MS spectra of m/z 1066.00 and m/z 876.94 signals at m/z
265.95 and 627.05, were detected, respectively (Figure 2). These masses were previously found in the
LC/ESI-Q-ToF-MS/MS spectrum of the microcystin [9-acetyl-Adda5]-MC-RR [30]. Other important
diagnostic signals such as m/z 135 corresponding to 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-
deca-4,6-dienoic acid (Adda) fragment, or m/z 163 corresponding to acetyl-Adda side chain were
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spectrum of  the Sephadex G‐50  fraction called Zs G50‐III. The mass spectrum shows absolute  ion 
intensity (a.i) versus mass‐to‐charge ratio (m/z) of Zs G50‐III components for the mass range m/z 700 
to 1350. 
Figure 1. Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF) mass
spectrum of the Sephadex G-50 fraction called Zs G50-III. The mass spectrum shows absolute ion intensity
(a.i) versus mass-to-charge ratio (m/z) of Zs G50-III components for the mass range m/z 700 to 1350.
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Figure 2. Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF)
mass-spectra of two peaks of interest from fraction Zs G50-III. (a) Analysis of m/z 1066.00 is shown,
highlighting the intense signal at m/z 876.94; and (b) analysis of the m/z 876.94. This signal occurred in
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analysis of two signals from fraction  s  50‐III  ass spectrum. The figure shows the relative inte sity 
(r.int) versus mass‐to‐charge ratio ( /z). (a)  L I‐T F/TOF analysis of m/z 1050.04, where the most 
intense signal corresponds to m/z 860.97; and (b) MALDI‐TOF/TOF analysis of m/z 861.01. 
In  addition,  the  signal  of m/z  1050.04 matched  a  reported microcystin, MC‐(H4) YR  [31,32]. 








Figure 3. Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF)
analysis of two signals from fraction Zs G50-III mass spectrum. The figure shows the relative intensity
(r.int) versus mass-to-charge ratio (m/z). (a) MALDI-TOF/TOF analysis of m/z 1050.04, where the
most intense signal corresponds to m/z 860.97; and (b) MALDI-TOF/TOF analysis of m/z 861.01.
In addition, the signal of m/z 105 .04 matched a reported microcy tin, MC-(H4) YR [31,32].
Within the most intense signals m/z 860.97 nd m/z 861.97 were found, resembling isotopic p aks
(Figure 3). Similarly, in the MALDI-TOF analysis o fraction Zs G50-III, the /z 861.01 was detected as
one of the most intense signals. In addition, the f gmentation pattern of m/z 105 .04 and m/z 861.01
showed some common si nals (Figure 3). Contrasting with the analysis of /z 1066.00, it was not
possible to match the fragments of m/z 1050 with known signals fro the fragmentation of MC-(H4)
YR [31]. The dia o tic fragments an otation w s hindered because of the limited information from
the MC-(H4) YR m/z 1050 spectrum. Moreover, in this case, the spectrum also lacked the microcystins
diagnostic signals like Adda fragments m/z 135 and m/z 163 [30].
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Moreover, some microcystin-related m/z signals were detected in the MALDI-TOF analysis of
Zs G50-III within the m/z range 960–1050 (Figure 4). These signal are m/z 960.0830, microcystin YA
(MC-YA) [33]; m/z 981.0593, demethylated variant of MC-LR ([DMAdda5]microcystin-LR) [32]; m/z
995.0931, MC-LR (microcystin-LR) [34]; m/z 1002.1186, [D-Asp3.Ser7]microcystin-E(OMe)E(OMe) [35]
or microcystin LY (MC-LY) [36]; m/z 1010.0557, [D-Asp3.Dha7]microcystin-RR [37]; m/z 1024.0260,
[D-Asp3]microcystin-RR [38]; m/z 1029.1227, microcystin FR (MC-FR) [39]; m/z 1039.0340,
[D-Ser1. ADMAdda5]microcystin-LR [40]; m/z 1045.0357, microcystin YR (MC-YR) [34] or
[Dha7]microcystin-HtyR [41]. However, these m/z signals were not successfully sequenced by MS/MS
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Figure 4. The figure shows absolute intensity (a.i) versus mass-to-charge ratio (m/z) in the m/z range
960–1050 from the MS analysis of fraction Zs G50-III. Some masses are highlighted as annotations,
considering similar m/z matches as possible microcystins.
2.3. Zs G50-III Reserved-Phase Chromatographic Analysis
2.3.1. RP-HPLC Analytical Profile
The detection of s me m rocystin-related m/z signals, pro pted the performance of an analytical
chromatographic step to ensure the identification of micr cysti s. Taking into account that the signal
m/z 995.09 matched MC-LR, as the most co monly known and widely distributed microcystins,
efforts were focused on confirming the presence of MC-LR in the sample. Therefore, the fraction
Zs G50-III was first analysed by RP-HPLC in analytical mode to obtain preliminary information on
the sample complexity. The analytical chromatogram showed what we considered as nine peaks
of moderate intensity, where the highest relative absorbance was produced by the less retained
compounds (Figure 5). Additionally, some of the peaks detected in the analytical chromatogram of
the fraction Zs G50-III produced UV spectra with a λmax at 220 and 274 nm, while the other peaks’
UV maximum-absorbance were around 233, 260, and 300 n (Supplementary Figure S1), c ose to the
maxi um absorb nce f microcystins.
In addition, a chromatogram was obtained with a commercial standard of MC-LR in analytical
mode in the same conditions as mentioned for fraction Zs G50-III (Figure 5). The elution time for
the MC-LR standard was 8.8 min, whereas in the analytical mode three closely-eluting peaks at 7.3,
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8.0, and 8.6 min were detected. Unlike MC-LR, such peaks do not show maximum absorbance at























Figure 6. Chromatogram of  fraction Zs G50‐III subjected  to reversed‐phase C18 HPLC  in  isocratic 
mode with 10% MeOH using a 0.1% TFA/H2O/MeOH elution system. After 15 min the solvent was 





reported  as  cyanopeptolin  [47].  However,  the  isomerization  [48]  and  co‐elution  with  another 
congeners, like cyanopeptolin [47,49] and microginin [50], can produce unusual UV spectra. The co‐
occurrence  of  cyanotoxins with  other  congeners  is  a  common  fact  supporting  the  possibility  of 
components co‐elution. It is noteworthy the presence of putative co‐eluting components detected by 
MS of the peak 2 (Supplementary Figure S3). Unfortunately, the amount of the fraction was limited, 
Figure 5. Analytical profile of fraction Zs G50-III, obtained by RP-HPLC. Gradient elution started from
1% to 99% MeOH over 55 min. The injected volume was 10 µL at a concentration of 1 mg/mL. The PDA
range was 210–400 nm, with fixed wavelengths at 220 nm and 280 nm. The peak of the commercial
standard of MC-LR (in red line) eluted at a retention time of 8.8 min. The injected volume was 10 µL
at a concentration of 1 mg/mL. The UV spectrum of MC-LR shows maximum absorbance at 238 nm,
typical of microcystins.
2.3.2. Zs G50-III RP-HPLC Semi-Preparative Assays
Afterwards, a semi-preparative RP-HPLC run (Figure 6) was carried out to separate those components
with retention time like that of the commercial MC-LR chromatogram (Figure 5). Unlike microcystins,
the UV maximum absorbance for the first peak was 264 nm, whereas the second peak showed a UV
maximum absorbance at 220–274 nm (Supplementary Figure S2), resembling a typical UV spectra of
peptides [42–45]. In contrast to Liquid chromatography combining multi-stage mass spectrometry
(MC-LC/MS), UV-based methods do not provide unequivocal identification of known, unexpected
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reported  as  cyanopeptolin  [47].  However,  the  isomerization  [48]  and  co‐elution  with  another 
congeners, like cyanopeptolin [47,49] and microginin [50], can produce unusual UV spectra. The co‐
occurrence  of  cyanotoxins with  other  congeners  is  a  common  fact  supporting  the  possibility  of 
components co‐elution. It is noteworthy the presence of putative co‐eluting components detected by 
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Figure 6. Chromatogram of fraction Zs G50-III subjected to reversed-phase C18 HPLC in isocratic
mode with 10% MeOH using a 0.1% TFA/H2O/MeOH elution system. After 15 min the solvent
was increased from 10% to 99% MeOH over 30 min. The chromatogram obtained by the RP-HPLC
procedure shows relative absorbance at 220–280 nm of two peaks and their respective retention times
of 8.2 min for peak 1 and 10.7 min for peak 2.
Nonetheless, the UV spectra of the peaks were not clearly related to MC-LR. Other cyclopeptides
with similar elution time, maximum UV absorbance at 220–274 nm and m/z 995 were previously
reported as cyanopeptolin [47]. However, the isomerization [48] and co-elution with another congeners,
like cyanopeptolin [47,49] and microginin [50], can produce unusual UV spectra. The co-occurrence
of cyanotoxins with other congeners is a common fact supporting the possibility of components
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co-elution. It is noteworthy the presence of putative co-eluting components detected by MS of the
peak 2 (Supplementary Figure S3). Unfortunately, the amount of the fraction was limited, and further
purification steps based on the gradient elution with phosphoric acid as the mobile phase was not
possible to perform as previously reported [50].
2.4. Identification of MC-LR by MALDI-TOF/TOF Analysis
The two peaks obtained by RP-HPLC were first submitted to MALDI-TOF MS scan resulting
in the detection of m/z values common to both peaks, such as m/z 795.3, 912.3, 926.4, 930.3; 944.4;
995.5, 1007.4, 1011.5, and 1029.5 (Figure 7). Nonetheless, some differences were detected in the
peak list and signal intensity, among which the m/z 765.33 showed the highest intensity in peak 1,
whereas 995.53 was the most intense m/z signal in peak 2. The mentioned m/z 995.53 was successfully
sequenced via MS/MS analysis of peak 2 (Figure 8) and the resulting spectrum matched the m/z values
of some fragments produced by MS/MS analysis of MC-LR (Figure 8). Some fragments from the
MS/MS of m/z 995.53 were successfully annotated, including m/z 135, as a diagnostic characteristic of
microcystins. Some of the fragments detected were annotated, such as m/z 70.07 [Arg-related ion],
m/z 135.09 [Adda fragment], m/z 375.15 [Adda-fragment + Glu + H], 599.27 [Arg + Adda + Glu + H],
and 861.33 [M-134]. Others m/z signals, like 1224.59, 1471.68, 1731.82, and 1866.87, corresponding
to co-eluting components to the MC-LR (m/z 995.53), were also successfully fragmented on peak 2,
(Supplementary Figure S3). Although, it was not possible to identify them, the m/z signal 1731.82 and
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Figure 7. Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF)
mass spectrum of the two RP-HPLC peaks. The composite figure shows relative intensity (r.int) versus
mass-to-charge ratio (m/z) in the range of m/z 700–1075 of peak 1 (blue) peak 2 (green).
























reports  on  the  occurrence  of  microcystins  in  marine  ecosystems  producing  hepatic  necrosis, 
haemorrhage, and sudden death in marine mammals [23,61]. The most significant report produced 
by microcystins intoxication produced the death of 21 southern sea otters [23]. The land‐sea flow with 







Figure 8. The figure shows relative intensity (r.int) versus mass-to-charge ratio (m/z) or the spectrum
generated by MALDI-TOF/TOF of the signal m/z 995.53 from peak 2 (color blue, top panel) and
the MS/MS of 1 µg of an MC-LR commercial standard (blue, bottom panel). Note similarities in the
fragmentation pattern in both spectra; the most relevant ions in the identification of the MC-LR are
annotated in the top panel.
2.5. Putative Origins of Microcystins in the Zs G50-III Fraction
Cyan bacteri also known as blue-gre algae are a widely distributed group of photosynthetic
prokaryotic organisms [32,52,53]. Some genera like Microcystis, Planktothrix, Anabaena, Nostoc,
and Nodularia can produce diverse toxins called cyanotoxins [32]. Within them, the microcystins
mostly produced by Microcystis aeruginosa, comprise more than 100 variants of such cyanotoxin [54].
The microcystins are synthesized via a non-ribosomal pathway, where peptide synthetases (NRPS)
and polyketide synthases (PKS) play an important role [55]. The general structural of these cyclic
heptapeptides are: cyclo [D-Ala(1)–L-X(2)–DMeAsp(3)–L-Z(4)–Adda(5)–D-Glu(6)–Mdha(7)], where
L-X and L-Z in position 2 and 4 of the ring are variable L-amino acids, D-MeAsp is a non-proteogenic
aminoacid D-erythro-b-methylaspartic acid, Mdha is N-methyldehydroalanine [56]. The Adda, that
is (2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid, is a diagnostic
characteristic of microcystins. Each microcystin is named depending on the identity of X and Z amino
acids [30].
Cyanobacteria toxins are more common in world-wide freshwater ecosystems [57,58], although
cyanobacteria are widespread in estuarine and marine systems, as well [59,60]. However, there
are reports on the occurrence of microcystins in marine ecosystems producing hepatic necrosis,
haemorrhage, and sudden death in marine mammals [23,61]. The most significant re ort produced
by microcystins intoxication produced the death of 21 southern sea otters [23]. The land-sea flow
wit trophic transfer t rough the marine invertebrate-producing bioaccumulatio process was
demons ated. It is n teworthy that our specimens belong to the inverteb ate Z. sociatus, sampled at
the Quibú river mout , in Havana City. Mo eover, this river passes through the city and is likely to be
eutr phyzed, providing the proper conditions for the occurrence of microcystins.
Additionally, the confirmation of microcystin-contaminated freshwater outflows to the ocean is
not an isolated and sporadic event [23–27]. There is also evidence of microcystins in some marine
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animals, like copepods, corals, and fish [28,62,63]. In addition, bioaccumulation of microcystins have
been detected on fresh and saltwater mussels [64,65], farmed crustaceans [66,67], fishes [63], and
probably in humans [68]. In our case, the cyanobacteria-producing toxins should come from the river
flow to the marine zone, occurring as a guest of Z. sociatus until being fed. Then microcystins can be
incorporated into the Z. sociatus tissues. Therefore, we suggest that the most probable source of the
toxins detected in our sample is an external producer and not a product of the zoanthid Z. sociatus.
However, the hypothesis of Z. sociatus as responsible for the production of microcyistin should not be
completely discharged, since an analogue of microcystins, called motuporin (analogue of Nodularin-R),
was first isolated and described in the marine sponge Theonella swinhoei [69].
Taking into account the high toxicity of microcystins on mammals, specifically in mice [70], the
presence of microcystins in the studied fraction could be related to the lethal effects on mice previously
reported of a LMW fraction from Z. sociatus [19]. In fact, MC-LR and its congeners are highly toxic
in mice (lethal dose: LD50 = 50 µg/kg) when administered intraperitoneally [71]. Unlike Zs G50-III,
mostly of the known MC-LR toxic effects are hepatotoxic. In addition, the mentioned studies lack of
enough elements to know if MC-LR was tested in an acute toxicity assay producing death in a short
time. Nonetheless, the possibilities of MC-LR be involved in cardiotoxic effects could not be discharged,
since it is capable of modulating Ca2+ channels. Indeed, the presence of microcystins on the fraction
Zs G50-III could also be related to the effects on insulin secretion mediated by Ca2+ influx blockade
in isolated rat β cells [18]. In fact, exposure to MC-LR for 72 h suppresses cell viability, disturbs
glucose-stimulated insulin secretion, and decreases the expression of insulin protein [72]. Although it
is not clear if the presence of microcystins are responsible for the mentioned effects, they are probably
largely involved.
3. Conclusions
The present work represents one of the few attempts to identify new peptide toxins from the
zoanthid Z. sociatus. However, the mass spectrometry analysis of a fraction from Z. sociatus resulted in
the detection of masses below 2000 Da, among which none sea anemones-like toxins were detected
with the Protein Pilot protein identification software and Mascot algorithm search. Nonetheless, some
related microcystins masses were detected within the most intense signals generated by the mass
spectrometry analysis. One of them, m/z 995.53 resulted in a highly similar fragmentation pattern
than that of MC-LR standard. Most of the fragment produced by the ionization of the m/z 995.53
were successfully annotated, including m/z 135.09 [Adda fragment], as a diagnostic characteristic
of microcystins. The combination of the evidences detected led to confirm the presence of MC-LR
in the fraction Zs G50-III. To date, this finding constitutes one of the few pieces of evidence of such
cyanotoxin being detected in cnidarians, and the first report in the zoanthid Z. sociatus. In the cases
of m/z 1066.00 and 1050.04, we considered that the information provided by the MS/MS spectra is
insufficient to identify these signals as coming from microcystin [9-acetyl-Adda5]-MC-RR and MC-(H4)
YR, respectively. Additionally, the presence of microcystins in fishing areas with similar conditions
to that of the Z. sociatus sampling area remain unexplored in Cuba. Considering the mentioned
evidence, the occurrence of microcystins in fishes should be of high probability around the sampling
place. Therefore, these findings clearly suggest the underestimated risk of intoxication by microcystins
occurring in water and food in a tropical region.
4. Materials and Methods
4.1. Preparation of Crude Extract and Gel Filtration on Sephadex G-50
The preparation of the Z. sociatus crude extract was performed from wild-caught colonies sampled
at Quibú River mouth, in Havana, Cuba. The gel filtration chromatographic separation on Sephadex
G-50 were performed as previously described [19]. Briefly, Z. sociatus specimens were blended after
removing their stolonal bases. The whole-body homogenate was filtered through a spun glass mesh,
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and the filtrate was centrifuged twice in a Beckmann CS-6RK centrifuge at 1376× g for 30 min at 4 ◦C.
The supernatant was freeze-dried overnight and then submitted to fractionation on a Sephadex G-50.
The most prominent fraction of the chromatogram, called Zs G50-III was freeze-dried and stored for
subsequent experiments.
4.2. Mass Spectrometry Analysis and Database Search
Mass spectrometry analysis was performed by MALDI-TOF/TOF (4800 Plus MALDI-TOF/TOF
Analyzer; AB SCIEX, Framingham, MA, USA). Mass spectra were analysed with the Data Explorer
software (v3.7, build 126, AB SCIEX, Framingham, MA, USA). The samples obtained in the
semi-preparative HPLC-PDA separation, corresponding to peaks 2, 3, 4, 5, and 6, were co-crystallized
at room temperature with the matrix α-cyano-4-hydroxycinnamic acid, α-CHCA at 10 mg/mL (50%
acetonitrile, and 0.1% trifluoroacetic acid (TFA)) in a MALDI target plate. Samples were previously
concentrated and cleaned according to the manufacturer’s instructions on a micro C18 column (ZipTip,
Millipore, Bedford, MA, USA). The mass spectra were acquired in positive ion reflector mode from m/z
700 to 4000. Afterwards, some of these peptides peaks were selected for MS/MS peptide sequencing.
The masses [M + H]+ and the corresponding native intensity of HPLC-PDA peaks obtained from
MS scan were exported to ASCII format for further analysis with the mMass 5.5.0 software [73,74].
Firstly, Peak Lists was achieved using the following criteria: peak’s signal-to-noise ratio threshold
(S/N) 2.0; absolute intensity threshold (a.i) 10.0 (peak’s native intensity without baseline correction);
relative intensity threshold (r.int.) 0.3 (peak’s relative intensity, in percentage of the most intense peak);
and picking height of 75. Additionally, baseline correction, smoothing, and deisotoping tools were
also applied to all MS fixed at default settings. The matrix α-CHCA monoisotopic masses [M + H]+
acquired in the same MS mass window were used as control for calibration. The resulting peak lists
were compared to each other using a tolerance of 0.1 Da and different masses were determined. Finally,
all different candidates’ masses [M + H]+ were corroborated in each MS (each MS-peak-spectrum
against MS-matrix-spectrum) in both mode Autoscale and Normalize View.
The data generated by MALDI-TOF/TOF procedure were submitted to search with the Mascot
(Matrix-Science, London, UK) algorithm. The protein identification was carried out from UniProtKB
protein sequence database [29] in the Metazoa and Cnidaria section. The Mascot search parameters
were fixed as follows: up to two maximum trypsin missed cleavages, mass tolerance of 50 ppm,
cysteine carbamidomethylation (fixed modification), methionine oxidation (variable modification), and
a charge state of +1. The same data mentioned were also analysed by Protein Pilot protein identification
software v4.5 (AB SCIEX). The protein identification was carried out from UniProtKB protein sequence
database in the Metazoa and Cnidaria section. Only those proteins matched with scores at a 95%
confidence level were considered as significant hits.
Moreover, all spectra generated for each peak were also analyzed by a mass-matching tool
provided by the mMass software v5.5.0 [73,74]. In this case, the analysis was carried out within
the internal monomer mMass library and also against the imported non-ribosomal peptides library
(NORINE peptide database, available in the mMass homepage at the download section http://www.
mmass.org/download/), adapted from the original NORINE database [21]. The matched masses
were then examined, and their spectra were analyzed. The fragmentation pattern was compared to
a standard or available reference, in the case of those that were of interest.
MALDI-TOF/TOF Raw Data Availability
The output files generated by MALDI-TOF/TOF analyses used in this work are provided in ASCII
format as Supplementary Raw Dataset S1. Within the package are included the following folders
containing the respective mass spectra (MS/MS): Matrix (MALDI TOF/TOF MS of matrix used as
control; MS_Zs G50-III (MS of studied fraction Zs G50-III); MS/MS_1066_&_876 (MS/MS of the signals
m/z 1066.00 and 876.94 from the MS of fraction Zs G50-III); MS/MS_1050_&_861 (MS/MS of the
signals m/z 1050.04 and 861.01 from the MS of fraction Zs G50-III); Peak 1 (MS of Peak 1 was obtained
Toxins 2017, 9, 89 11 of 16
by RP-PHLC from Zs G50-III fraction); Peak 2 (MS of Peak 2 was obtained by RP-PHLC from the Zs
G50-III fraction, and the MS/MS of the signals m/z 995.53, 1224.59, 1471.68, 1731.82, and 18,866.87),
and MS_&_MS/MS_MC-LR (MS of the commercial standard of MC-LR, and MS/MS of the signals
m/z 995.53 and 981.50 were obtained from the MS of MC-LR).
4.3. Reserved-Phase Chromatographic Analysis
All solvents used in RP-HPLC analyses were of high-purity chromatography grade (LiChrosolv,
Merck, Darmstadt, Germany). Aqueous solutions were prepared with ultrapure water supplied
from a Millipore water purification system (0.0054 µS·cm−1). Trifluoroacetic acid (TFA) was of
spectrophotometric grade 99%. The chromatographic system used for RP-HPLC separations was
a Waters Alliance e2695 HPLC coupled with a photodiode array (PDA) 2998 and an automatic fraction
collector. Empower Two Chromatography Data Software was used for calculation and reporting peak
information. All HPLC solvents were filtered (Pall GH Polypro 47 mm, 0.2 µm) and degassed by an
ultrasonic bath.
The analytical profile was obtained on a Merck Lichrospher RP-18 endcapped reversed-phase
column (250 mm × 4.6 mm i.d., 5 µm) equipped with a guard column (4 × 4 mm, 5 µm), both kept
at 40 ◦C. The PDA wavelength range was 210-800 nm with fixed values at 220 and 280 nm. The
solvent system consisted of MilliQ water (H2O) and methanol (MeOH), both acidified with 0.1% TFA.
A linear gradient from 1% to 99% MeOH was applied in the analytical run to explore the complexity
of the sample and the elution time of the commercial standard of Microcystin-LR (DHI Water and
Environment, Denmark; Batch No: MCLR-111).
The purification step was performed using a Phenomenex Luna RP-18 (25 cm × 10 mm, 10 µm)
chromatographic column kept at 35 ◦C. The PDA range was 210–800 nm with fixed wavelengths
of 220 and 280 nm. For the isocratic elution, 0.1% TFA in 10% MeOH was used as eluent at a
flow rate of 2.5 mL/min. Eventually, the solvent of the mobile phase was increased to 50% MeOH.
The concentration of total-proteins estimated was 1 mg/mL, and injected in a final volume of 200 µL.
The fractions were automatically collected following the PDA signal. The fractions of interest were
dried up by speed vac and kept at −20 ◦C for subsequent analysis.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/3/89/s1,
Figure S1: The figure shows the UV spectra of peaks obtained from the RP-HPLC analytical profile of
fraction ZsG50-III, Figure S2: The figure shows the UV spectra of two peaks obtained from the RP-HPLC
of the fraction ZsG50-III in a semi-preparative mode, Figure S3: Matrix assisted laser desorption/ionization
time-of-flight/time-of-flight(MALDI-TOF/TOF) mass spectra (MS) of the RP-HPLC Peak 2 and Supplementary
Raw Dataset S1.
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Abbreviations
The following abbreviations are used in this manuscript:
LMW Low molecular weight




int Peak’s corrected intensity
r.int Relative intensity
S/N Peak’s signal-to-noise ratio
mass Neutral mass
fwhm Full width at half maximum
resol resolution
NORINE Non-ribosomal peptide database
HPLC High Performance Liquid Chromatographic
RP Reverse Phase
MC-LR Microcystin LR
Z. sociatus Zoanthus sociatus
TTX tetrodotoxin
Palythoa caribaeorum P. caribaeourum
LC/ESI-Q-ToF
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